ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

HRTX Heron Therapeautics Inc

3,45
0,225 (6,98%)
19 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Heron Therapeautics Inc HRTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,225 6,98% 3,45 01:00:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,22 3,22 3,515 3,42 3,225
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.6.202422:43EDGAR2Form 8-K - Current report
17.6.202420:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.5.202417:08EDGAR2Form SC 13D/A - General statement of acquisition of..
29.5.202414:05EDGAR2Form 8-K - Current report
29.5.202414:05PRNUSHeron Therapeutics Announces Prior Approval Supplement..
07.5.202414:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.5.202414:05EDGAR2Form 8-K - Current report
07.5.202414:00PRNUSHeron Therapeutics Announces First Quarter 2024 Financial..
24.4.202414:00PRNUSHeron Therapeutics to Report First Quarter 2024 Financial..
11.4.202422:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
28.3.202421:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
13.3.202421:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
12.3.202421:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
12.3.202412:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
28.2.202414:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
14.2.202422:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202422:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24.1.202415:25APSPremarket Heats Up For Biotech Before Opening Bell
24.1.202414:01EDGAR2Form 8-K - Current report
24.1.202402:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
20.1.202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.1.202402:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202422:07EDGAR2Form 8-K - Current report
07.1.202423:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
22.12.202322:30EDGAR2Form 8-K - Current report
21.12.202323:25EDGAR2Form 8-K - Current report
06.12.202322:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21.11.202318:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202318:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202318:25APSBiotech Shares Up Sharply Following Quarterly Results
14.11.202322:10EDGAR2Form 8-K - Current report
14.11.202322:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
07.11.202322:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
18.10.202301:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.8.202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202322:08EDGAR2Form S-3 - Registration statement under Securities Act of..
14.8.202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:11EDGAR2Form 8-K - Current report
14.8.202322:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock